keyword
https://read.qxmd.com/read/38200656/folate-receptor-%C3%AE-deficiency-myelin-sensitive-mri-as-a-reliable-biomarker-to-monitor-the-efficacy-and-long-term-outcome-of-a-new-therapeutic-approach
#1
JOURNAL ARTICLE
Steffi Dreha-Kulaczewski, Prativa Sahoo, Matthias Preusse, Irini Gkalimani, Peter Dechent, Gunther Helms, Sabine Hofer, Robert Steinfeld, Jutta Gärtner
Cerebral folate transport deficiency, caused by a genetic defect in folate receptor α, is a devastating neurometabolic disorder that, if untreated, leads to epileptic encephalopathy, psychomotor decline and hypomyelination. Currently, there are limited data on effective dosage and duration of treatment, though early diagnosis and therapy with folinic acid appears critical. The aim of this long-term study was to identify new therapeutic approaches and novel biomarkers for assessing efficacy, focusing on myelin-sensitive MRI...
January 10, 2024: Journal of Inherited Metabolic Disease
https://read.qxmd.com/read/37543484/neurochemistry-evaluated-by-magnetic-resonance-spectroscopy-in-a-patient-with-fbxo28-related-developmental-and-epileptic-encephalopathy
#2
Kentaro Sano, Fuyuki Miya, Mitsuhiro Kato, Taku Omata, Jun-Ichi Takanashi
BACKGROUND: Mutations in the FBXO28 gene, which encodes FBXO28, one of the F-box protein family, may cause developmental and epileptic encephalopathy (DEE). FBXO28-related DEE is radiologically characterized by cerebral atrophy, delayed/abnormal myelination, and brain malformation; however, no neurochemical analyses have been reported. CASE REPORT: A female Japanese infant presented with severe psychomotor delay, epileptic spasms, and visual impairment. Whole-exome sequencing revealed a de novo variant of the FBXO28 gene, leading to the diagnosis of FBXO28-related DEE...
August 3, 2023: Brain & Development
https://read.qxmd.com/read/37141741/pyrroline-5-carboxylate-reductase-2-pycr2-deficiency-causes-hereditary-spastic-paraplaegia-in-late-childhood
#3
JOURNAL ARTICLE
Gunes Sager, Ayberk Türkyilmaz, Hediye Pınar Günbey, İbrahim Taş, Fatih Ozhelvaci, Yasemin Akin
OBJECTIVES: PYCR2 gene variants are extremely rare condition which is associated with hypomyelinating leukodystrophy type 10 with microcephaly (HLD10). The aim of the present study is to report the clinical findings of patients having novel PYCR2 gene variant that manifest Hereditary Spastic Paraplegia (HSP) is the only symptom without hypomyelinating leukodystrophy. This is the first study that report the PYCR2 gene variants as a cause of HSP in late childhood. We believe it can contribute to expanding the spectrum of the phenotypes associated with PYCR2...
May 2023: European Journal of Paediatric Neurology: EJPN
https://read.qxmd.com/read/36563646/mr-spectroscopy-in-metachromatic-leukodystrophy-a-model-free-approach-and-clinical-correlation
#4
JOURNAL ARTICLE
Joana Feldmann, Pascal Martin, Benjamin Bender, Lucia Laugwitz, Laimdota Zizmare, Christoph Trautwein, Ingeborg Krägeloh-Mann, Uwe Klose, Samuel Groeschel
BACKGROUND AND PURPOSE: Metachromatic leukodystrophy (MLD) is a lysosomal enzyme deficiency disorder leading to demyelination and subsequently to a progressive decline in cognitive and motor function. It affects mainly white matter where changes during the course of the disease can be visualized on T2-weighted MRI as hyperintense areas. Associated changes in brain metabolism can be quantified by MR spectroscopy (MRS) and may give complementary information as biomarkers for disease characterisation and progression...
December 20, 2022: NeuroImage: Clinical
https://read.qxmd.com/read/35822086/extremely-low-arylsulfatase-a-enzyme-activity-does-not-necessarily-cause-symptoms-a-long-term-follow-up-and-review-of-the-literature
#5
JOURNAL ARTICLE
Lucia Laugwitz, Vidiyaah Santhanakumaran, Mareike Spieker, Judith Boehringer, Benjamin Bender, Volkmar Gieselmann, Stefanie Beck-Woedl, Gernot Bruchelt, Klaus Harzer, Ingeborg Kraegeloh-Mann, Samuel Groeschel
Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by deficiency of arylsulfatase A (ARSA). Heterozygous carriers of disease-causing variants and individuals harbouring pseudodeficiency alleles in the ARSA gene exhibit reduced ARSA activity. In the context of these genotypes, low ARSA activity has been suggested to lead to an atypical form of MLD or other neurological abnormalities, but data are limited. The aim of our study was to analyse the impact of low ARSA activity in two subjects who are heterozygous for the ARSA pseudodeficiency allele and a disease-causing variant...
July 2022: JIMD Reports
https://read.qxmd.com/read/34448181/ketogenic-diet-for-kars-related-mitochondrial-dysfunction-and-progressive-leukodystrophy
#6
JOURNAL ARTICLE
Yuka Murofushi, Itaru Hayakawa, Yuichi Abe, Tatsuyuki Ohto, Kei Murayama, Hisato Suzuki, Toshiki Takenouchi, Kenjiro Kosaki, Masaya Kubota
KARS encodes lysyl-tRNA synthetase, which is essential for protein translation. KARS mutations sometimes cause impairment of cytoplasmic and mitochondrial protein synthesis, and sometimes lead to progressive leukodystrophies with mitochondrial signature and psychomotor regression, and follow a rapid regressive course to premature death. There has been no disease-modifying therapy beyond supportive treatment. We present a 5-year-old male patient with an asymmetrical leukodystrophy who showed overt evidence of mitochondrial dysfunction, including elevation of lactate on brain MR spectroscopy and low oxygen consumption rate in fibroblasts...
August 26, 2021: Neuropediatrics
https://read.qxmd.com/read/33226437/t2-pseudonormalization-and-microstructural-characterization-in-advanced-stages-of-late-infantile-metachromatic-leukodystrophy
#7
JOURNAL ARTICLE
Pascal Martin, Gisela E Hagberg, Thomas Schultz, Klaus Harzer, Uwe Klose, Benjamin Bender, Thomas Nägele, Klaus Scheffler, Ingeborg Krägeloh-Mann, Samuel Groeschel
PURPOSE: T2-weighted signal hyperintensities in white matter (WM) are a diagnostic finding in brain magnetic resonance imaging (MRI) of patients with metachromatic leukodystrophy (MLD). In our systematic investigation of the evolution of T2-hyperintensities in patients with the late-infantile form, we describe and characterize T2-pseudonormalization in the advanced stage of the natural disease course. METHODS: The volume of T2-hyperintensities was quantified in 34 MRIs of 27 children with late-infantile MLD (median age 2...
November 23, 2020: Clinical Neuroradiology
https://read.qxmd.com/read/30620693/adult-leukodystrophies-a-step-by-step-diagnostic-approach
#8
REVIEW
Lucas Lopes Resende, Anderson Rodrigues Brandão de Paiva, Fernando Kok, Claudia da Costa Leite, Leandro Tavares Lucato
Leukodystrophies usually affect children, but in the last several decades, many instances of adult leukodystrophies have been reported in the medical literature. Because the clinical manifestation of these diseases can be nonspecific, MRI can help with establishing a diagnosis. A step-by-step approach to assist in the diagnosis of adult leukodystrophies is proposed in this article. The first step is to identify symmetric white matter involvement, which is more commonly observed in these patients. The next step is to fit the symmetric white matter involvement into one of the proposed patterns...
2019: Radiographics: a Review Publication of the Radiological Society of North America, Inc
https://read.qxmd.com/read/29749055/aars2-related-ovarioleukodystrophy-clinical-and-neuroimaging-features-of-three-new-cases
#9
JOURNAL ARTICLE
I Taglia, I Di Donato, S Bianchi, A Cerase, L Monti, R Marconi, A Orrico, A Rufa, A Federico, M T Dotti
INTRODUCTION: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), previously known as hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) or pigmentary orthochromatic leukodystrophy (POLD), is the most frequent non-vascular adult-onset leukoencephalopathy. It is caused by autosomal dominant mutations in CSF1R gene. Recently, also autosomal recessive mutations in AARS2 gene were found to be the cause of an adult-onset leukodystrophy with axonal spheroids...
October 2018: Acta Neurologica Scandinavica
https://read.qxmd.com/read/29654549/severe-leukoencephalopathy-with-clinical-recovery-caused-by-recessive-bola3-mutations
#10
JOURNAL ARTICLE
C A Stutterd, N J Lake, H Peters, P J Lockhart, R J Taft, M S van der Knaap, A Vanderver, D R Thorburn, C Simons, R J Leventer
AIM: To identify the genetic aetiology of a distinct leukoencephalopathy causing acute neurological regression in infancy with apparently complete clinical recovery. METHODS: We performed trio whole genome sequencing (WGS) to determine the genetic basis of the disorder. Mitochondrial function analysis in cultured patient fibroblasts was undertaken to confirm the pathogenicity of candidate variants. RESULTS: The patient presented at 18 months with acute hemiplegia and cognitive regression without obvious trigger...
April 14, 2018: JIMD Reports
https://read.qxmd.com/read/29479774/hematopoietic-stem-cell-transplantation-in-late-onset-krabbe-disease-no-evidence-of-worsening-demyelination-and-axonal-loss-4-years-post-allograft
#11
JOURNAL ARTICLE
Cornelia Laule, Irene M Vavasour, Elham Shahinfard, Burkhard Mädler, Jing Zhang, David K B Li, Alex L MacKay, Sandra M Sirrs
BACKGROUND AND PURPOSE: Late-onset adult Krabbe disease is a very rare demyelinating leukodystrophy, affecting less than 1 in a million people. Hematopoietic stem cell transplantation (HSCT) strategies can stop the accumulation of toxic metabolites that damage myelin-producing cells. We used quantitative advanced imaging metrics to longitudinally assess the impact of HSCT on brain abnormalities in adult-onset Krabbe disease. METHODS: A 42-year-old female with late-onset Krabbe disease and an age/sex-matched healthy control underwent annual 3T MRI (baseline was immediately prior to HSCT for the Krabbe subject)...
May 2018: Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging
https://read.qxmd.com/read/29143062/-intracranial-cystic-lesions
#12
REVIEW
F Ahlhelm, K Shariat, S Götschi, S Ulmer
CLINICAL PROBLEM: Intracerebral cysts are common findings in imaging of the neurocranium and are not always clinically significant. The pathological spectrum of intracerebral cysts is, however, very broad and in addition to incidental findings includes developmental disorders, malformation tumors, primary and secondary neoplasms and infectious etiologies, such as cerebral abscess formation, cysticercosis or residuals after congenital cytomegalovirus infections. Intracerebral cystic defects may be caused by inflammatory central nervous system (CNS) diseases, such as multiple sclerosis as well as by mitochondriopathies, leukodystrophy, electrolyte disturbances or osmotic demyelination syndrome or brain infarctions, e...
February 2018: Der Radiologe
https://read.qxmd.com/read/29122497/further-delineation-of-the-phenotypic-spectrum-of-isca2-defect-a-report-of-ten-new-cases
#13
JOURNAL ARTICLE
Majid Alfadhel, Marwan Nashabat, Muhammad Talal Alrifai, Hesham Alshaalan, Fuad Al Mutairi, Saif A Al-Shahrani, Barbara Plecko, Rawan Almass, Maysoon Alsagob, Faten B Almutairi, Ahmed Al-Rumayyan, Waleed Al-Twaijri, Mohammed Al-Owain, Robert W Taylor, Namik Kaya
Iron-Sulfur Cluster (ISC) biogenesis is a vital cellular process required to produce various ISC-containing proteins. These ISC proteins are responsible for essential functions such as glycine cleavage and the formation of lipoic acid, an essential cofactor of respiratory chain complexes. Defects in ISC biogenesis lead to multiple mitochondrial dysfunction syndromes including: ISCA2 with infantile onset leukodystrophy. Recently, a founder mutation, c.229G > A, p.Gly77Ser in ISCA2 was reported to cause Multiple Mitochondrial Dysfunction Syndrome type 4...
January 2018: European Journal of Paediatric Neurology: EJPN
https://read.qxmd.com/read/28889092/quantitative-mr-spectroscopic-imaging-in-metachromatic-leukodystrophy-value-for-prognosis-and-treatment
#14
JOURNAL ARTICLE
Diane F van Rappard, Antoine Klauser, Marjan E Steenweg, Jaap Jan Boelens, Marianna Bugiani, Marjo S van der Knaap, Nicole I Wolf, Petra J W Pouwels
OBJECTIVE: To determine whether proton magnetic resonance spectroscopic imaging is useful in predicting clinical course of patients with metachromatic leukodystrophy (MLD), an inherited white matter disorder treatable with haematopoietic cell transplantation (HCT). METHODS: 21 patients with juvenile or adult MLD (12 HCT-treated) were compared with 16 controls in the same age range. Clinical outcome was determined as good, moderate or poor. Metabolites were quantified in white matter, and significance of metabolite concentrations at baseline for outcome prediction was assessed using logistic regression analysis...
January 2018: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/28130616/investigation-of-the-motor-system-in-two-siblings-with-canavan-s-disease-a-combined-transcranial-magnetic-stimulation-tms-diffusion-tensor-imaging-dti-study
#15
JOURNAL ARTICLE
V K Kimiskidis, Vasileios Papaliagkas, S Papagiannopoulos, D Zafeiriou, D Kazis, E Tsatsali-Foroglou, Z Kouvatsou, V Kapina, D Koutsonikolas, G Anogianakis, T Geroukis, S Bostantjopoulou
Canavan's disease (CD) is a hereditary leukodystrophy caused by mutations in the aspartoacylase gene (ASPA), leading to spongiform degeneration of the white matter and severe impairment of psychomotor development. We present the cases of two non-Jewish sisters with CD that have a milder and protracted clinical course compared to typical CD. MRI imaging revealed bilateral high-signal-intensity areas in the thalami and the internal capsule and MR spectroscopy showed typical findings for CD (a marked increase in N-acetylaspartate (NAA) levels)...
April 2017: Metabolic Brain Disease
https://read.qxmd.com/read/27432661/clinical-magnetic-resonance-spectroscopy-of-the-central-nervous-system
#16
REVIEW
Eva-Maria Ratai, R Gilberto González
Proton magnetic resonance spectroscopy (1H MRS) is a noninvasive imaging technique that can easily be added to the conventional magnetic resonance (MR) imaging sequences. Using MRS one can directly compare spectra from pathologic or abnormal tissue and normal tissue. Metabolic changes arising from pathology that can be visualized by MRS may not be apparent from anatomy that can be visualized by conventional MR imaging. In addition, metabolic changes may precede anatomic changes. Thus, MRS is used for diagnostics, to observe disease progression, monitor therapeutic treatments, and to understand the pathogenesis of diseases...
2016: Handbook of Clinical Neurology
https://read.qxmd.com/read/26189928/brain-magnetic-resonance-metabolic-and-microstructural-changes-in-adult-onset-autosomal-dominant-leukodystrophy
#17
JOURNAL ARTICLE
Stefano Zanigni, Rossana Terlizzi, Caterina Tonon, Claudia Testa, David Neil Manners, Sabina Capellari, Roberto Gallassi, Roberto Poda, Laura Ludovica Gramegna, Giovanna Calandra-Buonaura, Luisa Sambati, Pietro Cortelli, Raffaele Lodi
INTRODUCTION: adult-onset autosomal dominant leukodystrophy (ADLD) is a rare inherited disorder due to a duplication of lamin-B1 (LMNB1) gene. The aim of this study was to investigate brain metabolic and microstructural alterations by using advanced MR techniques. METHODS: we performed brain MR scans including single-voxel proton-MR Spectroscopy ((1)H-MRS) of the lateral ventricles and parietal white matter and diffusion tensor imaging (DTI) in 4 subjects with LMNB1 gene duplication, 6 non-mutated relatives and 7 unrelated healthy controls...
August 2015: Brain Research Bulletin
https://read.qxmd.com/read/26000324/sulfatide-levels-correlate-with-severity-of-neuropathy-in-metachromatic-leukodystrophy
#18
JOURNAL ARTICLE
Christine Í Dali, Norman W Barton, Mohamed H Farah, Mihai Moldovan, Jan-Eric Månsson, Nitin Nair, Morten Dunø, Lotte Risom, Hongmei Cao, Luying Pan, Marcia Sellos-Moura, Andrea M Corse, Christian Krarup
OBJECTIVE: Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disorder due to deficient activity of arylsulfatase A (ASA) that causes accumulation of sulfatide and lysosulfatide. The disorder is associated with demyelination and axonal loss in the central and peripheral nervous systems. The late infantile form has an early-onset, rapidly progressive course with severe sensorimotor dysfunction. The relationship between the degree of nerve damage and (lyso)sulfatide accumulation is, however, not established...
May 2015: Annals of Clinical and Translational Neurology
https://read.qxmd.com/read/25604618/refsum-disease-presenting-with-a-late-onset-leukodystrophy
#19
JOURNAL ARTICLE
Flavie Bompaire, Véronique Marcaud, Emmanuelle Le Trionnaire, Frédéric Sedel, Thierry Levade
Adult Refsum disease is an autosomal recessive peroxisomal disorder characterized by phytanic acid storage. Clinical symptoms usually begin in late childhood before the age of 20. Typical clinical presentation includes nyctalopia caused by retinitis pigmentosa, and anosmia. After 10-15 years, deafness, cerebellar ataxia, polyneuropathy, ichthyosis, and cardiac arrhythmia can occur.We report the case of a very late-onset adult Refsum disease presenting with marked cognitive decline and severe leukoencephalopathy, without peripheral nervous system involvement...
2015: JIMD Reports
https://read.qxmd.com/read/25289702/highly-efficient-ketone-body-treatment-in-multiple-acyl-coa-dehydrogenase-deficiency-related-leukodystrophy
#20
JOURNAL ARTICLE
Matthias Gautschi, Christian Weisstanner, Johannes Slotboom, Esmeralda Nava, Theres Zürcher, Jean-Marc Nuoffer
BACKGROUND: Multiple acyl-CoA dehydrogenase deficiency- (MADD-), also called glutaric aciduria type 2, associated leukodystrophy may be severe and progressive despite conventional treatment with protein- and fat-restricted diet, carnitine, riboflavin, and coenzyme Q10. Administration of ketone bodies was described as a promising adjunct, but has only been documented once. METHODS: We describe a Portuguese boy of consanguineous parents who developed progressive muscle weakness at 2...
January 2015: Pediatric Research
keyword
keyword
210522
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.